Pinichjindasup Akkaphol, Homvises Boonlawat, Muengtaweepongsa Sombat
J Med Assoc Thai. 2014 Aug;97 Suppl 8:S223-7.
Therapeutic hypothermia has been recently approved to show benefits for neurological outcomes in patients after cardiac arrest. Application of both ECMO and surface coolingfor treatment of therapeutic hypothermia has not yet been reported in the literature. We reported four cases that experienced in-hospital cardiac arrest during ECMO application treated with therapeutic hypothermia under surface cooling at Thammasat University Hospital.
Four cases ofin-hospital cardiac arrest during ECMO application were treated with therapeutic hypothermia under surface cooling with similar machine. The characteristics ofeach patient were described. The core temperature control during treatment was reported with temperature curves. A Glasgow coma score was used as index for neurological outcome
Application of surface cooling together with extracorporeal membrane oxygenation (ECMO) is safe and feasible. Both devices facilitate treatment with therapeutic hypothermia in patients with post-cardiac arrest.
治疗性低温疗法最近已被证实对心脏骤停后患者的神经功能转归有益。体外膜肺氧合(ECMO)与体表降温联合应用于治疗性低温疗法的情况尚未见文献报道。我们报告了在泰国国立法政大学医院,4例在应用ECMO期间发生院内心脏骤停的患者,接受了体表降温下的治疗性低温疗法。
4例在应用ECMO期间发生院内心脏骤停的患者,使用类似设备接受了体表降温下的治疗性低温疗法。描述了每位患者的特征。通过温度曲线报告了治疗期间的核心温度控制情况。采用格拉斯哥昏迷评分作为神经功能转归指标。
体表降温与体外膜肺氧合(ECMO)联合应用是安全可行的。这两种设备有助于对心脏骤停后患者进行治疗性低温治疗。